PARIS, July 30, 2015 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports
results for the second quarter of 2015. CEO Olivier Brandicourt comments on the group's
results and its performance in different businesses.
Watch video interview and read transcript:
http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview include:
- Q2 results
- Performance drivers
- Diabetes
- Praluent
- Innovation
- Immuno-oncology
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs.
Sanofi has core strengths in diabetes solutions, human vaccines,
innovative drugs, consumer healthcare, emerging markets, animal
health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
SOURCE Sanofi